Navigation Links
European Science Foundation aims to strengthen 'regenerative medicine'
Date:6/19/2008

14 Member Organisations* of the European Science Foundation have launched a key initiative to keep Europe at the forefront of regenerative medicine; broadly defined as the development of stem cell therapies to restore lost, damaged, or ageing cells and tissues in the human body.

Stem cells are the body's 'master cells' that have not yet been programmed to perform a specific function. Most tissues have their own supply of stem cells, and it is becoming clear that if these cells can be given the appropriate biochemical instructions, they can 'differentiate' into new tissue. In this way, for example, stem cells could be seeded into damaged heart muscle to repair it.

Regenerative medicine has many advantages over more conventional ways of repairing or replacing damaged tissues or organs. Because the stem cells are taken from the person being treated, there are no problems with the body's immune system recognising the cells as 'foreign' and attempting to reject them, something that is still a problem with organ transplantation, for example.

To help ensure that Europe retains its competitive edge in the field, the ESF has launched REMEDIC, a research networking programme in regenerative medicine (13 May 2008). For the next five years a steering committee of 13 of Europe's leading specialists in regenerative medicine will organise a series of meetings and workshops to bring together experts to share ideas and develop new collaborations.

"I think this network will be very important to allow scientists in the field to share and disseminate information," says Professor Yrj Konttinen, of Biomedicum Helsinki in Finland, who chairs the steering committee. "The network is open, so we will be in contact with many different organisations with an interest in the field. We want to meet people, establish joint collaborations with existing programmes and we will also be seeking funding for new initiatives."

REMEDIC will concentrate on the potential of a particular type of cell in the body called mesenchymal stromal cells. These can be obtained from fat tissue and coaxed to differentiate into a range of cell types, including bone, cartilage and muscle. Once the cells are in the relevant tissue, their growth and proliferation can be protected by biomaterials, which are structures implanted into the body that can guide the growth of the new tissue.

REMEDIC's first workshop is planned for mid-August in Helsinki, and a call for short term and exchange visits will be launched in late 2008. REMEDIC is a Research Networking Programme managed by the European Medical Research Councils (EMRC) at the European Science Foundation.


'/>"/>

Contact: Dr. Fiona Kernan
fkernan@esf.org
33-388-762-180
European Science Foundation
Source:Eurekalert

Related biology news :

1. Last chance for media to register for ECCO 14 -- the European Cancer Conference
2. 2 French scientists win European award for communication
3. Three-way mating game of North American lizard found in distant European relative
4. European lead in reading past climates from ice cores
5. Hot spots the key to controlling European carp in Australia
6. IdentiPHI Opens Paris Office to Boost European Sales and Support
7. European Union forests expanding, absorbing carbon at surprisingly high rate: study
8. First European Lung Cancer Conference
9. ESFs European ice core project EPICA receives prestigious Descartes Prize
10. European membrane expertise to focus on new treatments for human diseases
11. European light research opens door for optical storage and computing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2019)... NEW YORK (PRWEB) , ... November 19, 2019 , ... ... Crowne Plaza Times Square in New York City. The one-day event will be chaired ... diverse group of leaders in the space. , “We are witnessing significant innovation ...
(Date:11/14/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell ... for stem cell treatment of knee osteoarthritis . The first treatment came shortly after ... Biopharma. , In July of 2019, PSC received FDA approval for a ...
(Date:11/12/2019)... Ore. (PRWEB) , ... November 12, 2019 , ... ... launching Cross-Channel Spend Optimizer that improves digital advertising performance up to 25% and ... Digital Advertising, Cross-Channel Spend Optimizer uses advanced multi-touch attribution (MTA) to predict best ...
Breaking Biology News(10 mins):
(Date:11/22/2019)... Calif. (PRWEB) , ... November 21, 2019 , ... Lajollacooks4u ... team building and cooking events company already scheduled several of its popular cooking classes ... Holiday Parties. , The company’s Holiday Parties have been a favorite for ...
(Date:11/12/2019)... ... November 12, 2019 , ... REPROCELL Inc. a stem cell ... Lantern Pharma to provided preclinical screening and drug sensitivity for its portfolio of ... panels of unique and genetically edited cell lines from various tumors. The data ...
(Date:11/12/2019)... ... November 12, 2019 , ... Bode Technology (Bode) ... Forensic Genealogy, Melinde Lutz Byrne, to the organization. Byrne’s team will strengthen efforts ... leads to law enforcement through proven genealogy and DNA analysis methods. , Byrne’s ...
(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... Diversified ... whole pieces of fruits and vegetables per hour to improve processing. , The DTI ... of multiple tons per hour to increase juice yields by up to 50% and ...
Breaking Biology Technology: